ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,723.89
0.00%
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs Yen
157.2625
0.00%
Brent Oil
81.295
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Arbutus Biopharma Corporation (ABUS)

  7. Arbutus Biopharma Corporation (ABUS) ニュース

ABUS

Arbutus Biopharma (ABUS)

Arbutus Biopharma Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ABUS
日付受信時刻ニュースソース見出しコード企業名
2024/05/2920 : 30GlobeNewswire Inc.Arbutus to Participate in Jefferies Global Healthcare ConferenceNASDAQ:ABUSArbutus Biopharma Corporation
2024/05/2905 : 25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABUSArbutus Biopharma Corporation
2024/05/2505 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABUSArbutus Biopharma Corporation
2024/05/2505 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABUSArbutus Biopharma Corporation
2024/05/2219 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABUSArbutus Biopharma Corporation
2024/05/2215 : 00GlobeNewswire Inc.Arbutus to Present Imdusiran Data at EASL Congress 2024NASDAQ:ABUSArbutus Biopharma Corporation
2024/05/1722 : 03Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ABUSArbutus Biopharma Corporation
2024/05/1722 : 03Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ABUSArbutus Biopharma Corporation
2024/05/1722 : 00Business WireWhitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize ValueNASDAQ:ABUSArbutus Biopharma Corporation
2024/05/0921 : 00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ABUSArbutus Biopharma Corporation
2024/05/0720 : 30GlobeNewswire Inc.Arbutus to Participate in Two Upcoming Investor ConferencesNASDAQ:ABUSArbutus Biopharma Corporation
2024/05/0220 : 30GlobeNewswire Inc.Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ABUSArbutus Biopharma Corporation
2024/05/0220 : 25GlobeNewswire Inc.Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024NASDAQ:ABUSArbutus Biopharma Corporation
2024/04/1820 : 30GlobeNewswire Inc.Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate UpdateNASDAQ:ABUSArbutus Biopharma Corporation
2024/04/0421 : 30GlobeNewswire Inc.Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against ModernaNASDAQ:ABUSArbutus Biopharma Corporation
2024/03/0821 : 30GlobeNewswire Inc.Arbutus to Participate in Two Upcoming Investor ConferencesNASDAQ:ABUSArbutus Biopharma Corporation
2024/03/0606 : 48Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ABUSArbutus Biopharma Corporation
2024/02/2921 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABUSArbutus Biopharma Corporation
2024/02/2921 : 30GlobeNewswire Inc.Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate UpdateNASDAQ:ABUSArbutus Biopharma Corporation
2024/02/1521 : 30GlobeNewswire Inc.Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate UpdateNASDAQ:ABUSArbutus Biopharma Corporation
2024/02/1506 : 38Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABUSArbutus Biopharma Corporation
2024/02/1500 : 48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABUSArbutus Biopharma Corporation
2024/02/0609 : 55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABUSArbutus Biopharma Corporation
2024/02/0609 : 55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABUSArbutus Biopharma Corporation
2024/02/0609 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABUSArbutus Biopharma Corporation
2024/02/0609 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABUSArbutus Biopharma Corporation
2024/01/0821 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABUSArbutus Biopharma Corporation
2024/01/0821 : 30GlobeNewswire Inc.Arbutus Announces 2024 Corporate Objectives and Provides Financial UpdateNASDAQ:ABUSArbutus Biopharma Corporation
2024/01/0506 : 09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABUSArbutus Biopharma Corporation
2023/11/2122 : 00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABUSArbutus Biopharma Corporation
 Showing the most relevant articles for your search:NASDAQ:ABUS

最近閲覧した銘柄

BIT
P20185
NLBNPIT20185 20991231 1....
NASDAQ
PAYOW
Payoneer Global
BIT
UB03TW
UniCredit Bank
NYSE
DLR-A.CL
BIT
F18754
Vontobel Financial Produ...
EU
CDCJG
Caisse des Depots et Con...
TKOK
TRXUSDT
TRON
EU
CDCLV
Caisse des Depots et Con...
LSE
58MN
Perm.mast.1b
USOTC
EFBI
Eagle Financial Bancorp (QB)
KUCN
KARUSDT
Karura
NYSE
GATO
Gatos Silver
EU
CAFSM
Credit Agricole CIB Fina...
USOTC
DHCC
Diamondhead Casino (PK)
BIT
P1VA96
NLBNPIT1VA96 20991231 52...
HUOB
DHTETH
dHEDGE DAO
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有